JP2021517171A5 - - Google Patents

Download PDF

Info

Publication number
JP2021517171A5
JP2021517171A5 JP2021502678A JP2021502678A JP2021517171A5 JP 2021517171 A5 JP2021517171 A5 JP 2021517171A5 JP 2021502678 A JP2021502678 A JP 2021502678A JP 2021502678 A JP2021502678 A JP 2021502678A JP 2021517171 A5 JP2021517171 A5 JP 2021517171A5
Authority
JP
Japan
Prior art keywords
benzaldehyde
water
propoxy
mmol
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021502678A
Other languages
English (en)
Japanese (ja)
Other versions
JP7029213B2 (ja
JP2021517171A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2019/003514 external-priority patent/WO2019190172A1/ko
Publication of JP2021517171A publication Critical patent/JP2021517171A/ja
Publication of JP2021517171A5 publication Critical patent/JP2021517171A5/ja
Application granted granted Critical
Publication of JP7029213B2 publication Critical patent/JP7029213B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2021502678A 2018-03-26 2019-03-26 新規な化合物およびこれを含む肥満または代謝症候群の予防または治療用薬学的組成物 Active JP7029213B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862648381P 2018-03-26 2018-03-26
US62/648,381 2018-03-26
PCT/KR2019/003514 WO2019190172A1 (ko) 2018-03-26 2019-03-26 신규한 화합물 및 이를 포함하는 비만 또는 대사증후군의 예방 또는 치료용 약학적 조성물

Publications (3)

Publication Number Publication Date
JP2021517171A JP2021517171A (ja) 2021-07-15
JP2021517171A5 true JP2021517171A5 (enExample) 2021-08-26
JP7029213B2 JP7029213B2 (ja) 2022-03-03

Family

ID=68060316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021502678A Active JP7029213B2 (ja) 2018-03-26 2019-03-26 新規な化合物およびこれを含む肥満または代謝症候群の予防または治療用薬学的組成物

Country Status (8)

Country Link
US (1) US12065394B2 (enExample)
EP (1) EP3778555A4 (enExample)
JP (1) JP7029213B2 (enExample)
KR (1) KR102054399B1 (enExample)
CN (1) CN112105598B (enExample)
AU (1) AU2019243133B2 (enExample)
TW (1) TWI717712B (enExample)
WO (1) WO2019190172A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11666661B2 (en) 2018-03-23 2023-06-06 The Regents Of The University Of California Methods and compounds for targeted autophagy
US12383624B2 (en) 2018-07-24 2025-08-12 Seoul National University R&Db Foundation Cargo delivery system and composition comprising the same
EP3828163A4 (en) 2018-07-24 2022-05-18 Protech Co., Ltd. NOVEL P62 LIGAND COMPOUND AND COMPOSITION TO PREVENT, MITIGATE OR TREAT PROTEINOPATHIES THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5495046A (en) 1991-01-04 1996-02-27 Taisho Pharmaceutical Co., Ltd. Alkoxyphenylalkylamine derivatives
NO179246C (no) 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
JP3421702B2 (ja) * 1993-03-26 2003-06-30 大正製薬株式会社 シグマ受容体拮抗薬
US6458849B1 (en) * 1999-09-23 2002-10-01 G.D. Searle & Co. use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activity
MX2009000715A (es) 2006-07-19 2009-07-22 Osurf Ohio State University Re Moduladores de receptor de androgeno selectivos, analogos y derivados de los mismos.
CN103930166B (zh) 2011-08-08 2018-07-06 解向群 p62小分子化学抑制剂
KR101594168B1 (ko) 2013-10-02 2016-02-15 서울대학교산학협력단 p62의 ZZ 영역에 의해 매개되는 자가포식 조절 방법 및 그 용도
AU2016274576A1 (en) * 2015-06-11 2017-12-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education p62-ZZ chemical inhibitor
KR101731908B1 (ko) 2015-08-18 2017-05-11 서울대학교산학협력단 p62 ZZ 도메인에 결합하는 리간드 또는 아르기닌화된 BiP에 의해 매개되는 오토파지 활성을 통한 신경변성 질환 예방 및 치료

Similar Documents

Publication Publication Date Title
JP2021517171A5 (enExample)
JP2005179362A5 (enExample)
CN111201212A (zh) 一种非罗考昔及其中间体的合成方法
JP2017507961A (ja) 単一の溶媒を用いるクロミフェン合成
CN102911022A (zh) 一种天然姜黄素类物的人工合成方法
CN101307024A (zh) 5-正丁基-2-乙基胺基-6-甲基嘧啶-4-基二甲基胺基磺酸酯的合成方法
CN103880683B (zh) 一种3-溴-2-硝基苯甲醛的化学合成方法
CN102180773B (zh) 一种白藜芦醇的制备方法
CN114409519A (zh) 一种顺式茉莉酮的合成方法
CN1942434B (zh) 茚衍生物及其制备方法
CN111499544B (zh) 一种一锅法制备N-Boc-N-甲基-4-氨基苯乙烯的合成方法
CN104447447A (zh) 一个新的化合物及其制备方法和消除方法
CN101250173B (zh) 一种螺甲螨酯的制备方法
CN110746393B (zh) 3-甲硫基取代的苯并呋喃类化合物的合成方法
JP2020515553A (ja) 1−(4−メタンスルホニル−2−トリフルオロメチル−ベンジル)−2−メチル−1H−ピロロ[2,3−b]ピリジン−3−イル−酢酸を調製するためのプロセス
CN103864747B (zh) 倒捻子素的全合成方法
CN111454315B (zh) 一种雄甾-16-烯-3β-醇的合成方法
JP5199096B2 (ja) エポキシ化合物およびアルデヒドの調製方法
JP2019509293A (ja) 4−ペンタフルオロチオフェノール類化合物と調製方法及びペンタフルオロサルファー置換ベンゾピラン化合物の調製方法
CN106631686A (zh) 一种β‑苯乙醇的制备方法
CN114292198A (zh) 一种文拉法辛杂质的制备方法
WO2022051980A1 (zh) 用于制备sglt抑制剂中间体的合成方法
US9290428B2 (en) Process for the preparation of derivatives of 1-(2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid
JP6764158B2 (ja) カルボニル化合物の製造方法
JP5803031B2 (ja) ペレチノインの向上した合成